References

1. Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clinical Journal of the American Society of Nephrology. 2016;11(6):1102-13.
2. Harmon QE, Huang L, Umbach DM, Klungsøyr K, Engel SM, Magnus P, et al. Risk of fetal death with preeclampsia. Obstetrics and gynecology. 2015;125(3):628.
3. Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. The Lancet. 2016;387(10017):462-74.
4. Lee QY, Odoi AT, OPARE‐ADDO H, Dassah ET. Maternal mortality in Ghana: a hospital‐based review. Acta obstetricia et gynecologica Scandinavica. 2012;91(1):87-92.
5. Dassah ET, Kusi-Mensah E, Morhe ES, Odoi AT. Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana. PloS one. 2019;14(10):e0223478.
6. Salam RA, Das JK, Ali A, Bhaumik S, Lassi ZS. Diagnosis and management of preeclampsia in community settings in low and middle-income countries. J Family Med Prim Care. 2015;4(4):501-6.
7. Rawlins B, Plotkin M, Rakotovao JP, Getachew A, Vaz M, Ricca J, et al. Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries. BMC Pregnancy and Childbirth. 2018;18(1):346.
8. Jim B, Karumanchi SA, editors. Preeclampsia: pathogenesis, prevention, and long-term complications. Seminars in nephrology; 2017: Elsevier.
9. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the placenta: the role of reactive oxygen species signaling. BioMed research international. 2015;2015.
10. Anto EO, Roberts P, Turpin CA, Wang W. Oxidative stress as a key signaling pathway in placental angiogenesis changes in preeclampsia: updates in pathogenesis, novel biomarkers and therapeutics. Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics). 2018;16(3):167-81.
11. Yoshida A, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Wakatsuki A. Placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction. The Journal of Maternal-Fetal & Neonatal Medicine. 2018;31(8):1051-7.
12. Wu F, Tian F-J, Lin Y, Xu W-M. Oxidative Stress: Placenta Function and Dysfunction. American Journal of Reproductive Immunology. 2016;76(4):258-71.
13. Lou W-z, Jiang F, Hu J, Chen X-x, Song Y-n, Zhou X-y, et al. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women. Disease Markers. 2019;2019.
14. Honigberg M, Cantonwine D, Thomas A, Lim K, Parry S, McElrath T. Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia. Journal of Perinatology. 2016;36(3):172-7.
15. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine. 2009;22(11):1021-38.
16. Anto EO, Roberts P, Coall DA, Adua E, Turpin CA, Tawiah A, et al. Suboptimal health pregnant women are associated with increased oxidative stress and unbalanced pro-and antiangiogenic growth mediators: a cross-sectional study in a Ghanaian population. Free Radical Research. 2020;54(1):27-42.
17. Anto EO, Roberts P, Coall D, Turpin CA, Adua E, Wang Y, et al. Integration of suboptimal health status evaluation as a criterion for prediction of preeclampsia is strongly recommended for healthcare management in pregnancy: a prospective cohort study in a Ghanaian population. EPMA Journal. 2019;10(3):211-26.
18. Agrawal S, Cerdeira AS, Redman C, Vatish M. Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study. Hypertension. 2018;71(2):306-16.
19. Caillon H, Tardif C, Dumontet E, Winer N, Masson D. Evaluation of sFlt-1/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center. Annals of laboratory medicine. 2018;38(2):95-101.
20. Turpin CA, Sakyi SA, Owiredu WKBA, Ephraim RKD, Anto EO. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnancy and Childbirth. 2015;15(1):189.
21. Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients]. Zeitschrift fur Geburtshilfe und Neonatologie. 2014;218(1):34-41.
22. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. American journal of obstetrics and gynecology. 2012;206(1):58.e1-8.
23. Pratt A, Da Silva Costa F, Borg AJ, Kalionis B, Keogh R, Murthi P. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis. 2015;18(2):115-23.
24. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nature clinical practice Nephrology. 2005;1(2):98-114.
25. O’Brien M, Baczyk D, Kingdom JC. Endothelial dysfunction in severe preeclampsia is mediated by soluble factors, rather than extracellular vesicles. Scientific reports. 2017;7(1):1-12.
26. Chuchracki M, Pisarska M, Krzyścin M. The role of sFLT-1 and PlGF factors as well as the sFLT-1/PlGF ratio as a predictor of gestational hypertension and preeclampsia. Arch Perinat Med. 2017;23(2):97-104.
27. Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, et al. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC pregnancy and childbirth. 2014;14(1):35.
28. Weel IC, Baergen RN, Romão-Veiga M, Borges VT, Ribeiro VR, Witkin SS, et al. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia. PLOS ONE. 2016;11(6):e0157584.
Table 1. Demographics, obstetrics, single biomarkers of OS and AGMs and their combination among SHS and OHS pregnant women who developed EO-PE and LO-PE compared to NTN-P